Compare Hims and Hers Health Inc (HIMS) vs S&P500 ETF (SPY) Price & Performance

HIMS stock trades at $29.97, down 1.77% amid mixed Q2 2026 results. Revenue growth remains strong at $2.6B for 2026, but profitability concerns persist with a net loss of $142M and negative margins. Technical indicators are neutral with support at $29 and resistance at $31. Recent news highlights multiple securities fraud investigations and FTC scrutiny.

The outlook is cautious. While revenue guidance was raised and analyst consensus targets $33, profitability erosion, margin pressure, and legal overhangs pose significant risks. The stock faces headwinds from declining cash flow and investor skepticism despite growth initiatives in AI and global expansion.

SPY, the SPDR S&P 500 ETF, trades at $772.47, up 0.27% today, near its all-time high with bullish technical signals from moving averages. The ETF reflects broad U.S. equity strength, buoyed by cooling inflation data and record S&P 500 levels. Recent news highlights index additions like Reddit and positive market sentiment, while a dividend of $1.90 is scheduled for July 2026.

Outlook remains positive given the S&P 500's momentum and economic tailwinds, but risks include potential market volatility from Fed policy shifts or inflation rebounds. The ETF offers diversified exposure to large-cap U.S. stocks, with analyst consensus favoring long-term growth, though overbought conditions suggest near-term caution.